Basic information Safety Supplier Related

BICALUTAMIDE-D4

Basic information Safety Supplier Related

BICALUTAMIDE-D4 Basic information

Product Name:
BICALUTAMIDE-D4
Synonyms:
  • BICALUTAMIDE-D4
  • Casodex-d4
  • ICI-176334-d4
  • N-[4-Cyano-3-trifluoromethyl)phenyl]- 3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide-d4
  • (CI-176334-D4
  • Bicalutamide Impurity 17
  • [2H4]-Bicalutamide
  • Propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl-2,3,5,6-d4)sulfonyl]-2-hydroxy-2-methyl-
CAS:
1185035-71-5
MF:
C18H10D4F4N2O4S
MW:
434.4
Product Categories:
  • Intermediates & Fine Chemicals
  • Isotope Labeled Compounds
  • Pharmaceuticals
  • Sulfur & Selenium Compounds
  • Isotope Labelled Compounds
Mol File:
1185035-71-5.mol
More
Less

BICALUTAMIDE-D4 Chemical Properties

Melting point:
192-1940C
Boiling point:
650.308±55.00 °C(Press: 760.00 Torr)(predicted)
Density 
1.522±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
storage temp. 
-20°C Freezer
solubility 
Chloroform (Slightly, Heated), Methanol (Slightly, Sonicated)
pka
11.492±0.29(predicted)
form 
Solid
color 
White to Off-White
More
Less

BICALUTAMIDE-D4 Usage And Synthesis

Description

Bicalutamide-d4 is intended for use as an internal standard for the quantification of bicalutamide by GC- or LC-MS. Bicalutamide is a non-steroidal androgen receptor antagonist that binds the androgen receptor (Ki = 12.5 μM; IC50 = 1.2 μM), preventing its activation and subsequent upregulation of androgen responsive genes by androgenic hormones. Bicalutamide is frequently used to examine the role of androgen receptor inactivation in the proliferation of prostate cancer cells and has served as a molecular template for the design and structural optimization of more selective androgen receptor modulators for androgen therapy.

Chemical Properties

BICALUTAMIDE-D4 is White Solid

Uses

BICALUTAMIDE-D4 is used as an antiandrogen, antineoplastic (hormonal). (94%d4; 5.7%d3, 0.1%d1, no d0

References

[1] SN FREEMAN  BJA F  WIP Mainwaring. A possible explanation for the peripheral selectivity of a novel non-steroidal pure antiandrogen, Casodex (ICI 176,334)[J]. British Journal of Cancer, 1989, 60 5: 664-668. DOI: 10.1038/bjc.1989.336
[2] DAVID MASIELLO. Bicalutamide Functions as an Androgen Receptor Antagonist by Assembly of a Transcriptionally Inactive Receptor*[J]. The Journal of Biological Chemistry, 2002, 28 1: 26321-26326. DOI: 10.1074/jbc.m203310200
[3] WENQING GAO J T D Juhyun Kim. Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands.[J]. Pharmaceutical Research, 2006, 23 8: 1641-1658. DOI: 10.1007/s11095-006-9024-3
[4] DONGHUA YIN. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.[J]. Molecular Pharmacology, 2003, 63 1: 211-223. DOI: 10.1124/mol.63.1.211

BICALUTAMIDE-D4Supplier

Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Cato Research Chemicals Inc.
Tel
020-81960175
Email
min.he@cato-chem.com
Hubei Yangxin Medical Technology Co., Ltd.
Tel
15374522761
Email
3003392093@yongstandards.com
Shenzhen Polymeri Biochemical Technology Co., Ltd.
Tel
+86-400-002-6226 +86-13028896684;
Email
sales@rrkchem.com
Guangzhou Dreampharm Biotechnology Co., Ltd.
Tel
020-36607679 19925672674
Email
3008233746@qq.com